Scinovex
article

Anemia in Chronic Kidney Disease (Ckd) Patients

International journal of applied research · 2015 · Vol. 1(12) · pp. 386–389

Abstract

Background: In patients with chronic kidney disease, norm chromic normocytic anaemia mainly develops from decreased renal synthesis of erythropoietin. The anaemia becomes more severe as the Glomerular filtration rate (GFR) progressively decreases. No reticulocyte response occurs, red blood cell survival is decreased and there is an associated increased bleeding tendency due to uraemiainduced platelet dysfunction. Untreated anaemia of CKD is strongly associated with cardiovascular and renal complications, resulting in increased hospitalisations and mortality. Therefore, correcting anaemia is considered an important part of slowing or even stopping the progression of CKD. [15] Methods: In the present study, 50 patients of CKD admitted at GG Hospital, a tertiary care hospital, Jamnagar during period of 1 year, were included. Results: In the present study, 58% patients have moderate, 22% have mild and 20% have severe form of anaemia Conclusion: As anaemia is common in developing country and CKD is affecting haemopoietic system, 78% patient of study having anaemia.

Erythropoietin and Anemia TreatmentHemoglobinopathies and Related DisordersDialysis and Renal Disease ManagementMedicineKidney diseaseAnemiaRenal functionErythropoietinInternal medicineReticulocyteBone marrowGastroenterology
Citations
0
FWCI
0.00
field-weighted impact
References
11
Percentile
22%
vs. same field & year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.